Table 1: Changes of the body weight (g) of rats in the seven groups during the experimental period of 30 days.

Before treatment48 h15 days30 days

N group178.3 ± 5.6183.4 ± 6.5214.3 ± 7.7220.3 ± 6.3
D group180.1 ± 6.9177.3 ± 5.9174.1 ± 10.2a169.3 ± 11.6a
N + G group176.9 ± 5.8186.1 ± 8.8209.6 ± 9.6b220.8 ± 10.0b
N + LG group179.3 ± 7.6183.0 ± 7.2187.6 ± 5.5a,b206.3 ± 5.9a,b
N + MG group177.4 ± 5.1180.6 ± 4.6190.6 ± 4.9a,b213.6 ± 9.9b
N + HG group178.6 ± 7.7186.9 ± 5.8199.5 ± 7.1a,b216.2 ± 7.8b
N + GLI group180.2 ± 6.3187.9 ± 5.0196.3 ± 6.1a,b212.1 ± 11.8b

Values are means ± SD for 10 rats in each group. N group: normal control; D group: diabetes group; N + G group: normal control plus GBE; D + LG group: diabetes plus low GBE treatment; D + MG group: diabetes plus middle GBE treatment; D + HG group: diabetes plus high GBE treatment; D + GLI group: diabetes plus glibenclamide treatment.
aIndicates statistical significance of compared to N group; b compared to D group.